<DOC>
	<DOCNO>NCT01273974</DOCNO>
	<brief_summary>The purpose study determine whether half-dose intradermal influenza vaccine immunogenic standard dose intramuscular vaccine hemodialysis patient .</brief_summary>
	<brief_title>The Immunogenicity Intradermal Influenza Vaccination Hemodialysis Patients</brief_title>
	<detailed_description>Hemodialysis patient high risk influenza infection due suppress immune status.It recommend immunize influenza annually.in intradermal vaccination antigens directly present large number antigen-presenting cell skin may cause great immunogenicity intramuscular method . Reduced-dose intradermal influenza vaccine immunogenic healthy adult , patient solid cancer three group immunocompromized patient include Rheumatologic patient treat anti-TNF , HIV-infected stem cell transplant patient . In study compare efficacy influenza vaccine half dose intradermal standard intramuscular method among hemodialysis patient .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Patients chronic hemodialysis history flu infection last month history flu vaccination 2009 hospitalization last month take immune suppressant drug hemodialysis less twice weekly</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>intradermal influenza vaccine</keyword>
	<keyword>hemodialysis patient</keyword>
</DOC>